Progressive supranuclear palsy (PSP) is a debilitating neurodegenerative disease characterized by progressive deterioration of motor control. Individuals with PSP often face significant obstacles in performing everyday functions. These constraints can encompass walking, balance, swallowing, and speech, profoundly impacting quality of life. Rehabili

while in the absence of curative treatment method, supportive and palliative steps are exceedingly critical (29–33). desk two summarizes the range of symptomatic and palliative treatments in ALS. relating to symptomatic cure of spastic leg weak spot, anti-spasticity medications, for instance baclofen or tizanidine, or subarachnoid infusions of ba